<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://fampra.oxfordjournals.org">
<title>Family Practice - recent issues</title>
<link>http://fampra.oxfordjournals.org</link>
<description>Family Practice - RSS feed of recent issues (covers the latest 3 issues, including the current issue) </description>
<prism:eIssn>1460-2229</prism:eIssn>
<prism:publicationName>Family Practice</prism:publicationName>
<prism:issn>0263-2136</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/169?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/171?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/174?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/180?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/183?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/188?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/196?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/204?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/210?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/221?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/3/231?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/79?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/81?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/88?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/96?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/102?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/109?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/115?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/121?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/128?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/137?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/145?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/154?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/2/163?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/1?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/3?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/10?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/22?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/27?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/34?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/40?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/48?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/56?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/65?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/69?rss=1" />
  <rdf:li rdf:resource="http://fampra.oxfordjournals.org/cgi/content/short/26/1/75?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/169?rss=1">
<title><![CDATA[Pharmaceutical representatives do influence physician behaviour]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/169?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Harris, G.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp033</dc:identifier>
<dc:title><![CDATA[Pharmaceutical representatives do influence physician behaviour]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>170</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>169</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/171?rss=1">
<title><![CDATA[Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes study]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/171?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Depression is a common complication of type 2 diabetes, associated with poor disease outcomes such as impaired glycaemic control, cardiovascular disease and increased mortality. The mechanisms behind these associations are unclear. Depression might contribute to poor disease outcomes through decreased physical activity.</p>
<p><b>Objective.</b> To test whether type 2 diabetes patients with elevated depression scores are more often physically inactive.</p>
<p><b>Methods.</b> Demographic features, clinical factors, level of physical inactivity and depressive symptoms were assessed in 2646 primary care patients with type 2 diabetes. Sequential multiple logistic regression analyses [odds ratio, 95% confidence interval (CI)] were performed to test the association between depressive symptoms and physical inactivity.</p>
<p><b>Results.</b> About 48% of the respondents were physically inactive. Elevated depressive symptoms were found in 14% of the respondents. After adjustment for potential confounders, the odds for being physically inactive were almost doubled in depressed patients with type 2 diabetes 1.74 (95% CI 1.32&ndash;2.31).</p>
<p><b>Conclusions.</b> Presence of depressive symptoms almost doubles the likelihood of physical inactivity in patients with type 2 diabetes. Longitudinal studies are needed to investigate whether physical inactivity forms the link between depression and poor disease outcomes.</p>
]]></description>
<dc:creator><![CDATA[Koopmans, B., Pouwer, F., de Bie, R. A, van Rooij, E. S, Leusink, G. L, Pop, V. J]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp016</dc:identifier>
<dc:title><![CDATA[Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes study]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>173</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>171</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/174?rss=1">
<title><![CDATA[Foot problems in children presented to the family physician: a comparison between 1987 and 2001]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/174?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> In recent decades, studies on the management of common foot problems in children have suggested that in many cases, there is no indication for treatment. It is not known whether these studies have changed daily practice.</p>
<p><b>Objective.</b> Our aim was to establish and compare incidence and referral rates for foot problems in children in 1987 and 2001.</p>
<p><b>Methods.</b> A comparison was made of two large consecutive surveys in Dutch general practice performed in 1987 (86 577 children aged 0&ndash;17 years) and 2001 (87 952 children aged 0&ndash;17 years), which were carried out by The Netherlands Institute for Health Services Research. Both surveys included a representative sample of the Dutch population. Incidence and referral rates were calculated and, data were stratified for age group and gender.</p>
<p><b>Results.</b> Compared to 1987, in 2001 the overall incidence rate of foot problems presented to the family physician (FP) decreased substantially from 80.0 [95% confidence interval (CI) 77.0&ndash;84.7] to 17.4 (95% CI 16.5&ndash;18.3) per 1000 person-years (<I>P</I> &lt; 0.0001). The incidence rate of flat feet decreased from 4.9 (95% CI 4.0&ndash;5.9) per 1000 person-years in 1987 to 3.4 (95% CI 3.0&ndash;3.8) per 1000 person-years in 2001 (<I>P</I> = 0.001). The distribution of referrals to other primary health care professionals and medical specialists has almost reversed in favour of primary health care professionals.</p>
<p><b>Conclusion.</b> Total incidence rate of musculoskeletal foot problems seen by the FP has decreased substantially, between 1987 and 2001.</p>
]]></description>
<dc:creator><![CDATA[Krul, M., van der Wouden, J. C, Schellevis, F. G, van Suijlekom-Smit, L. W., Koes, B. W]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp018</dc:identifier>
<dc:title><![CDATA[Foot problems in children presented to the family physician: a comparison between 1987 and 2001]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>179</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>174</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/180?rss=1">
<title><![CDATA[Over-representation of diabetic patients with renal anaemia in the primary care setting]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/180?rss=1</link>
<description><![CDATA[
<p><b>Aims.</b> Anaemia is a complication of chronic kidney disease (CKD); the National Institute for Clinical Excellence (NICE) have defined renal anaemia as estimated glomerular filtration rate (eGFR) &lt;60 ml/min/1.73 m<sup>2</sup> and haemoglobin (HB) &lt;11.0 g/dl. The purpose of this study was to see if diabetic patients have a higher prevalence in primary care of this new anaemia definition. Furthermore, we wished to determine whether diabetic patients were over-represented above HB 11.0 g/dl, which may lead to developing renal anaemia.</p>
<p><b>Methods.</b> We used an observational prevalence study in primary care from one Staffordshire practice in 2005&ndash;2006. Egton Medical Information Systems Ltd computer database was searched for patients with two Modification of Diet in Renal Disease eGFRs separated by 3 months, HB levels and medications.</p>
<p><b>Results.</b> From a list size of 1830 patients, 362 had two eGFRs &lt;60; of those, 308 had a HB available. In all, 29 (9.4%) patients had NICE renal anaemia, with over-representation of diabetic patients, 13 (16%) against 16 (7%) without diabetes (<I>P</I> &lt; 0.02). We found that diabetic patients were also over-represented at HB 11.0 to &lt;12.5 g/dl, 26 (32%) with diabetes and 39 (17.6%) without (<I>P</I> &lt; 0.001). Mean HB was significantly lower for the diabetic group (<I>n</I> = 81, 26%), 12.8 g/dl (95% Confidence Intervals (CI) 12.4&ndash;13.1) against non-diabetic group (<I>n</I> = 227, 74%), 13.4 g/dl (95% CI 13.2&ndash;13.6), <I>P</I> &lt; 0.01. Predictors of HB on multivariate regression analysis were female gender, eGFR and diabetes (all <I>P</I> &lt; 0.001).</p>
<p><b>Conclusions.</b> Diabetic patients were more likely to have NICE defined renal anaemia in this primary care population with CKD stages 3&ndash;5. This is similar to observations in secondary care settings. We observed over-representation of diabetic patients above NICE definition at HB 11.0 to &lt;12.5 g/dl.</p>
]]></description>
<dc:creator><![CDATA[Mostafa, S., Tagboto, S., Robinson, M., Burden, A., Davies, S.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp009</dc:identifier>
<dc:title><![CDATA[Over-representation of diabetic patients with renal anaemia in the primary care setting]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>182</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>180</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/183?rss=1">
<title><![CDATA[Intervention with educational outreach at large scale to reduce antibiotics for respiratory tract infections: a controlled before and after study]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/183?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> A multiple intervention targeted to reduce antibiotic prescribing with an educational outreach programme had proven to be effective in a randomized controlled trial in 12 peer review groups, demonstrating 12% less prescriptions for respiratory tract infections.</p>
<p><b>Objective.</b> To assess the effectiveness of a multiple intervention in primary care at a large scale.</p>
<p><b>Methods.</b> A controlled before and after study in 2006 and 2007 was designed. Participants were from general practices within a geographically defined area in the middle region of The Netherlands. Participants were GPs in 141 practices in 25 peer review groups. A control group of GP practices from the same region, matched for type of practice and mean volume of antibiotic prescribing. The multiple intervention consisted of the following elements: (i) group education meeting and communication training; (ii) monitoring and feedback on prescribing behaviour; (iii) group education for GPs and pharmacists assistants and (iv) patient education material. The main outcome measures are as follows: (i) number of antibiotic prescriptions per 1000 patients per GP and (ii) number of second-choice antibiotics, obtained from claims data from the regional health insurance company. The associations between predictors and outcome measurements were assessed by means of a multiple regression analyses.</p>
<p><b>Results.</b> At baseline, the number of antibiotic prescriptions per 1000 patients was slightly higher in the intervention group than in the control group (184 versus 176). In 2007, the number of prescriptions had increased to 232 and 227, respectively, and not differed between intervention and control group.</p>
<p><b>Conclusions.</b> The implementation of an already proven effective multiple intervention strategy at a larger scale showed no reduction of antibiotic prescription rates. The failure might be attributed to a less tight monitoring of intervention and audit. Inserting practical tools in the intervention might be more successful and should be studied.</p>
]]></description>
<dc:creator><![CDATA[Smeets, H., Kuyvenhoven, M., Akkerman, A., Welschen, I, Schouten, G., van Essen, G., Verheij, T.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp008</dc:identifier>
<dc:title><![CDATA[Intervention with educational outreach at large scale to reduce antibiotics for respiratory tract infections: a controlled before and after study]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>187</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>183</prism:startingPage>
<prism:section>Health Services Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/188?rss=1">
<title><![CDATA[Designing an RCT of acupuncture for depression--identifying appropriate patient groups: a qualitative study]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/188?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Acupuncture is a popular complementary therapy choice for depression in the UK but the evidence base lags behind its usage. Further effectiveness trials are required; however, these need based on appropriate design for a complex intervention on a heterogeneous group of people.</p>
<p><b>Aim.</b> To identify subgroups of patients with depression who could be the focus of effectiveness trials.</p>
<p><b>Methods.</b> Qualitative research using in-depth interviews in UK primary care. In-depth interviews with 30 participants from three stakeholder groups: 10 acupuncture patients and 10 acupuncturists&mdash;to examine the reasons why acupuncture is used for depression and 10 physicians&mdash;to elicit who would be acceptable to refer into a trial of acupuncture for depression. Interviews were transcribed and analysed using a Framework approach.</p>
<p><b>Results.</b> The data have highlighted that the acceptability of particular treatments for depression is influenced by the individuals' illness career within their social context. In addition, the plausibility and associated acceptability of depression treatments are also closely tied to an individuals' explanatory model of their condition. Seven patient subgroups were identified who could potentially find acupuncture of particular interest and on which effectiveness trials could be focused.</p>
<p><b>Conclusions.</b> We have identified the main reasons why people seek acupuncture for depression and the circumstances in which physicians would be willing to refer for depression were it to prove effective. We have also set out a number of potential patient subgroups who may be particularly interested participating in a randomized controlled trail of acupuncture for depression.</p>
]]></description>
<dc:creator><![CDATA[Schroer, S., MacPherson, H., Adamson, J.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp021</dc:identifier>
<dc:title><![CDATA[Designing an RCT of acupuncture for depression--identifying appropriate patient groups: a qualitative study]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>195</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>188</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/196?rss=1">
<title><![CDATA['Is it normal to feel these questions ...?': a content analysis of the health concerns of adolescent girls writing to a magazine]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/196?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> There is a mismatch between presenting concerns of adolescents to GPs and behaviours that lead to adolescent morbidity and mortality. Better understanding of health concerns of this target group would enhance communication between health professionals and adolescent patients.</p>
<p><b>Objective.</b> To explore and categorize the health concerns of adolescent girls sending unsolicited emails to a teenage girls&rsquo; magazine.</p>
<p><b>Method.</b> We conducted a content analysis of 1000 systematic randomly selected unsolicited emails submitted to the health column of an Australian adolescent girls&rsquo; magazine over a 6-month period.</p>
<p><b>Results.</b> Three main foci of concern were identified: Context of Concern, Health Issue of Concern and Advice Sought for Concern. Within Health Issue of Concern, there were five categories: body (47.5%), sex (31.9%), relationship (14.7%), mind (4.7%) and violence and/or safety (1.2%). Concerns within the body and sex categories ranged enormously, but frequently expressed intimate descriptions of anatomy, feelings, sexual practices and relationships. Many concerns occurred in the context of adolescents&rsquo; relationships with others. The proportion of concerns about physical or psychological symptoms or health issues commonly associated with the adolescent age group (such as health risk behaviours, mental health, pregnancy and sexually transmitted infections) was relatively small.</p>
<p><b>Conclusions.</b> GPs and other health professionals might engage more readily with adolescent patients with a deeper understanding of the concerns that adolescents have about their bodies, relationships and overall health. Seemingly &lsquo;trivial&rsquo; issues, such as normal puberty, could be used as discussion triggers in health consultations to help alleviate anxiety and build rapport.</p>
]]></description>
<dc:creator><![CDATA[Kang, M., Cannon, B., Remond, L., Quine, S.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp019</dc:identifier>
<dc:title><![CDATA['Is it normal to feel these questions ...?': a content analysis of the health concerns of adolescent girls writing to a magazine]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>203</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>196</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/204?rss=1">
<title><![CDATA[Impact of pharmaceutical representative visits on GPs' drug preferences]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/204?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Pharmaceutical representative visits are believed to have substantial impact, but the effects on prescribing patterns have not been systematically evaluated.</p>
<p><b>Objective.</b> This study investigates how pharmaceutical sales representative visits influenced physicians&rsquo; company-specific drug preferences and prevalence of steroid prescribing.</p>
<p><b>Methods.</b> Observational cohort study in Funen County, Denmark, including 165 general practices visited 832 times by pharmaceutical representatives and 54 080 patients treated with asthma drugs. Visits were conducted from 2001 to 2003. Our main outcome measures were (i) company-specific drug preferences measured as the proportion of dispensings of the promoted drug among all dispensings of fixed combinations of inhaled corticosteroid and long-acting &beta;<SUB>2</SUB>-agonists and (ii) the proportion of patients receiving repeated &beta;<SUB>2</SUB>-agonist dispensings who were treated with inhaled steroids.</p>
<p><b>Results.</b> The first visit had a statistically significant effect on the GPs&rsquo; drug preference in favour of the marketed drug [odds ratio (OR), 2.39; 95% confidence interval (CI), 1.72&ndash;3.32]. The effect on drug preference increased further after the second visit (OR, 1.51; 95% CI, 1.19&ndash;1.93), while there was no significant change after the third visit (OR, 1.06; 95% CI, 0.94&ndash;1.20). Pharmaceutical sales representative visits did not influence the overall treatment pattern with inhaled steroids (OR, 1.01; 95% CI, 0.97&ndash;1.06).</p>
<p><b>Conclusions.</b> Pharmaceutical sales representative visits markedly increased the market share of the promoted drug, but only the two first visits had significant impact. Visits had no significant impact on GPs&rsquo; overall prescribing of inhaled steroids.</p>
]]></description>
<dc:creator><![CDATA[Sondergaard, J., Vach, K., Kragstrup, J., Andersen, M.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp010</dc:identifier>
<dc:title><![CDATA[Impact of pharmaceutical representative visits on GPs' drug preferences]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>209</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>204</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/210?rss=1">
<title><![CDATA[A tale of two systems: perceptions of primary care for depression in London and Melbourne]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/210?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Depression represents a major and growing disease burden. About 90% of depressed patients are treated solely in primary care, yet there are system-related barriers to primary care for people with depression in the UK and Australia, countries which have different health care arrangements.</p>
<p><b>Objectives.</b> The aim was to explore the views of GPs and patients in London and Melbourne about primary care system features which support or hinder best care for mild-to-moderate depression. The study differentiated between policy and reality &lsquo;on the ground&rsquo;.</p>
<p><b>Methods.</b> Two round Delphi technique methodology with four panels: GPs and patients in London and GPs and patients in Melbourne, to elicit views on the extent to which system features were reflected in policy, reflected in reality and were of value for best care.</p>
<p><b>Results.</b> Four themes were generated: system and financing, responsibility and continuity, consultations and primary care team. Patient-centred care, having sufficient time during a consultation, and the GP&ndash;patient relationship extending over time were rated highly by all panels. Panellists differentiated between policy and reality on a number of features.</p>
<p><b>Conclusions.</b> The Australian system does not guarantee continuity of care with practitioner or practice but patients took steps to see the same doctor for depression. There was a difference in the way London and Melbourne panels responded to finance-related statements. There was a tendency for panellists to value aspects of their own system and to fail to see possibilities of other systems.</p>
]]></description>
<dc:creator><![CDATA[Cronin, E., Campbell, S., Ashworth, M., Hann, M., Blashki, G., Murray, J., Tylee, A.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp017</dc:identifier>
<dc:title><![CDATA[A tale of two systems: perceptions of primary care for depression in London and Melbourne]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>220</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>210</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/221?rss=1">
<title><![CDATA[Cancer survivors' rehabilitation needs in a primary health care context]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/221?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Studies of cancer survivors&rsquo; rehabilitation needs have mostly addressed specific areas of needs, e.g. physical aspects and/or rehabilitation needs in relation to specific cancer types.</p>
<p><b>Objective.</b> To assess cancer survivors&rsquo; perceived need for physical and psychosocial rehabilitation, whether these needs have been presented to and discussed with their GP.</p>
<p><b>Methods.</b> A survey among a cohort of cancer survivors approximately 15 months after diagnosis. The questionnaire consisted of an <I>ad hoc</I> questionnaire on rehabilitation needs and the two validated questionnaires, the SF-12 and the Research and Treatment of Cancer quality of life questionnaire, the QLQ C-30 version 3.</p>
<p><b>Results.</b> Among 534 eligible patients, we received 353 (66.1%) answers. Two-thirds of the cancer survivors had discussed physical rehabilitation needs with their GPs. Many (51%) feared cancer relapse, but they rarely presented this fear to the GP or the hospital staff. The same applied to social problems and problems within the family. Good physical and mental condition and low confidence in the GP were associated with no contact to the GP after hospital discharge.</p>
<p><b>Conclusion.</b> Cancer survivors have many psychosocial rehabilitation needs and intervention should effectively target these needs. If this task is assigned to the GPs, they need to be proactive when assessing psychosocial aspects.</p>
]]></description>
<dc:creator><![CDATA[Mikkelsen, T., Sondergaard, J., Sokolowski, I., Jensen, A., Olesen, F.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp004</dc:identifier>
<dc:title><![CDATA[Cancer survivors' rehabilitation needs in a primary health care context]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>230</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>221</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/3/231?rss=1">
<title><![CDATA[Offering payments, reimbursement and incentives to patients and family doctors to encourage participation in research]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/3/231?rss=1</link>
<description><![CDATA[
<p>Sometimes researchers fail to meet their recruitment targets, and sometimes it is predicted that recruitment may prove difficult but it is not obvious what ethical latitude researchers have to boost participation by, for instance, paying participants to take part or by paying family doctors to recruit patients to participate. In this paper, we distinguish between payment, reimbursement and inducement. We look first at the ethics of paying research participants. We conclude that payment raises all kinds of ethical difficulties, but that reimbursement&mdash;whilst not completely unproblematic&mdash;is an ethical requirement. We then look at whether some inducement to participate is acceptable and conclude that it is. We continue by asking whether the same arguments can be applied to encouraging family doctors to recruit patients. We conclude that it is right for family doctors to be reimbursed for the costs of recruiting research participants and also argue that there are fewer problems with paying family doctors to recruit patients than there are with paying research participants. Given, however, that there is a fine line between reimbursement and payment, given the potential for conflicts of interests to arise, and given that even suspicion of such a conflict might undermine trust in doctors, systems of both payment and reimbursement need to be transparent.</p>
]]></description>
<dc:creator><![CDATA[Draper, H., Wilson, S., Flanagan, S., Ives, J.]]></dc:creator>
<dc:date>2009-05-29</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp011</dc:identifier>
<dc:title><![CDATA[Offering payments, reimbursement and incentives to patients and family doctors to encourage participation in research]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>238</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>231</prism:startingPage>
<prism:section>Review Article</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/79?rss=1">
<title><![CDATA[Multimorbidity in primary care: developing the research agenda]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/79?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mercer, S. W, Smith, S. M, Wyke, S., O'Dowd, T., Watt, G. C.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp020</dc:identifier>
<dc:title><![CDATA[Multimorbidity in primary care: developing the research agenda]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>80</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>79</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/81?rss=1">
<title><![CDATA[Do family physicians' records fit guideline diagnosed COPD?]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/81?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> In family practice, chronic obstructive pulmonary disease (COPD) is usually not diagnosed until clinically apparent and of moderately advanced severity.</p>
<p><b>Objective.</b> To analyse the diagnostic process from early development onwards and to assess the current state of underpresentation and underdiagnosis of COPD and asthma in primary care in the Netherlands.</p>
<p><b>Methods.</b> The population-based study sample consisted of formerly undiagnosed subjects (<I>n</I> = 532) from family practice. Family physicians&rsquo; (FPs) chronic respiratory disease diagnoses (as recorded over 10 years in their patient records) were compared to a cross-sectional but extensive diagnostic assessment by a chest physician. Logistic regression modelling was used for a retrospective analysis on the relation between respiratory symptoms, practice visit rate and FPs&rsquo; diagnosis of COPD.</p>
<p><b>Results.</b> After 10 years, the chest physician diagnosed 26% of subjects as COPD and 16% as (late-onset) asthma. Underpresentation of these patients in family practice was 46%, whereas underdiagnosis occurred in 37% of patients. A chest physician diagnosis of COPD was associated with the presence of chronic cough [odds ratio (OR) = 2.3, 95% confidence interval (CI) 1.1&ndash;4.6], a FP diagnosis of COPD with chronic phlegm (OR = 10.6, 95% CI 1.3&ndash;83.6). Repeated practice visits (OR = 1.8) and presence of wheeze and breathlessness (OR = 5.5) appeared to trigger the diagnostic process in family practice.</p>
<p><b>Conclusions.</b> There is still considerable underpresentation and underdiagnosis of COPD in family practice. As FPs focus on presented symptoms and as detection increases with the frequency of practice visits, diagnostic guidelines should stress the importance of persistent cough and phlegm to support timely diagnosis of COPD in family practice.</p>
]]></description>
<dc:creator><![CDATA[Albers, M., Schermer, T., Molema, J., Kloek, C., Akkermans, R., Heijdra, Y., van Weel, C.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp005</dc:identifier>
<dc:title><![CDATA[Do family physicians' records fit guideline diagnosed COPD?]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>87</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>81</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/88?rss=1">
<title><![CDATA[Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/88?rss=1</link>
<description><![CDATA[
<p><b>Introduction.</b> Musculoskeletal complaints are very common in primary care settings. Lipid-lowering drugs are one of several causes of musculoskeletal symptoms. However, data showing an association of lipid-lowering drug therapy and increased odds of musculoskeletal complaints in primary care patients are lacking.</p>
<p><b>Objective.</b> To investigate the association between statin use and the reporting of muscular complaints by patients and simultaneously control for several known factors of musculoskeletal complaints.</p>
<p><b>Methods.</b> In a cross-sectional study with 1031 consecutive patients (&gt;50 years of age) in 26 offices of GPs, two investigators collected the data from the office files and by interviewing the patients. A logistic regression model was used to identify variables affecting the odds of muscular symptoms.</p>
<p><b>Results.</b> The prevalence of lipid-lowering drug prescription was 23% (<I>n</I> = 239) and that of muscular complaints was 40% (<I>n</I> = 411). In all, 44% (<I>n</I> = 106) of the patients with lipid-lowering drug prescription had muscular complaints compared to 39% (<I>n</I> = 305) of the patients without lipid-lowering drug therapy. Statin prescription and 10 variables remained in the final model. Statin prescription is associated with a 1.5-fold odds of musculoskeletal complaints compared to non-prescription {odds ratio [OR] = 1.5 [95% confidence interval (CI), 1.1&ndash;2.0], <I>P</I> = 0.02}.</p>
<p><b>Conclusion.</b> Having a statin prescription appears to be an independent factor associated with musculoskeletal symptoms in primary care settings. Statin use may be more often associated with musculoskeletal complaints than previously assumed.</p>
]]></description>
<dc:creator><![CDATA[Mosshammer, D., Lorenz, G., Meznaric, S., Schwarz, J., Muche, R., Morike, K.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp006</dc:identifier>
<dc:title><![CDATA[Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>95</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>88</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/96?rss=1">
<title><![CDATA[Is the ebb of asthma due to the decline of allergic asthma? A prospective consultation-based study by the Swiss Sentinel Surveillance Network, 1999-2005]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/96?rss=1</link>
<description><![CDATA[
<p><b>Objective.</b> There are conflicting views on time trends of asthma and atopy during the last 10&ndash;15 years. Additional confusion is caused by the term of asthma which is a unifying name for different phenotypes. Asthma has been a topic for investigation to the Swiss Sentinel Surveillance Network (SSSN) since 1989. The objective of the actual study was to determine the influence of the allergic and non-allergic components of asthma on time trends from 1999 to 2005.</p>
<p><b>Methods.</b> Primary care physicians participating in the SSSN were guided by diagnostic criteria for asthma. Rates of asthma episodes per 1000 consultations were calculated for all, for first and subsequent asthma episodes and for allergic and non-allergic asthma. Allergic asthma was defined as asthmatic manifestations in conjunction with eczema and/or hay fever. The smoothed time trend and its 95% confidence intervals were determined using generalized additive models with a loess smoother adjusting for seasonality.</p>
<p><b>Results.</b> Consultations for allergic asthma have decreased between 1999 and 2005. Looking at different age groups, asthma associated with hay fever was reported with decreasing frequency in all age groups, whereas when associated with eczema, the other used marker of allergic asthma, slightly increased among young children.</p>
<p><b>Conclusions.</b> The decrease of consultations for asthma is most probably due to the allergic component of asthma. Diagnostic shift over time and ready available medications probably contributed to this phenomenon. Our findings indicate a real decline of allergic asthma.</p>
<p><b>Practice recommendations.</b> Consultations for asthma have decreased over recent years. The decrease of consultations for asthma is most probably due to the allergic component of asthma. Diagnostic shift over time and available medications probably contributed to this phenomenon. Strength of Recommendation Taxonomy (SORT) rating: strength of recommendation = C, level of evidence = 3.</p>
]]></description>
<dc:creator><![CDATA[Bollag, U., Grize, L., Braun-Fahrlander, C.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn104</dc:identifier>
<dc:title><![CDATA[Is the ebb of asthma due to the decline of allergic asthma? A prospective consultation-based study by the Swiss Sentinel Surveillance Network, 1999-2005]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>101</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>96</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/102?rss=1">
<title><![CDATA[Treatment satisfaction of diabetic patients: what are the contributing factors?]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/102?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Treatment satisfaction is an important factor of quality of care, especially in treating chronic diseases such as diabetes mellitus. Identifying factors that independently influence treatment satisfaction may help in improving clinical outcomes.</p>
<p><b>Objective.</b> To find the relationship between treatment satisfaction of diabetic patients and socio-demographic, clinical, adherence, treatment and health perception factors.</p>
<p><b>Methods.</b> Patients were interviewed by telephone about their socio-demographic parameters, health status, clinical data and treatment factors. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) was used to measure satisfaction and adherence. This is a cross-sectional study, as part of a larger study of chronic patients in Israel. Subjects were randomly selected diabetes patients. The main outcome measures were DTSQ levels. A multivariate linear regression model was constructed to identify factors independently associated with patients&rsquo; satisfaction.</p>
<p><b>Results.</b> In all, 630 patients were included in the study. Multivariate analysis indicated that demographic parameters (e.g. female gender, <I>P</I> = 0.036), treatment factors (e.g. type of medication, <I>P</I> &lt; 0.001), adherence factors (e.g. difficulty attending follow-up or taking medications, <I>P</I> &lt; 0.001) and clinical factors (e.g. diabetes complications, <I>P</I> &lt; 0.01) were independently associated with lower treatment satisfaction.</p>
<p><b>Conclusions.</b> Treatment satisfaction is lower among diabetic patients who have a lower educational level, who are insulin treated or have a diabetic complication and is related to difficulties in taking medications and coming to follow-up visits. Addressing the specific needs of these patients might be effective in improving their satisfaction, thus having a positive influence on other clinical outcomes.</p>
]]></description>
<dc:creator><![CDATA[Biderman, A., Noff, E., Harris, S. B, Friedman, N., Levy, A.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp007</dc:identifier>
<dc:title><![CDATA[Treatment satisfaction of diabetic patients: what are the contributing factors?]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>108</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>102</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/109?rss=1">
<title><![CDATA['Aiming for the stars'--GPs' dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus group interviews]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/109?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Studies have revealed low adherence to guidelines for treatment of diabetes and cardiovascular risk factors.</p>
<p><b>Objective.</b> To explore GPs' experiences regarding treatment practice in type 2 diabetes with specific focus on the prevention of cardiovascular disease.</p>
<p><b>Methods.</b> Fourteen experienced GPs from nine health care centres with group practices were interviewed in focus groups. The interviews were digitally recorded, transcribed verbatim and analysed by qualitative content analysis.</p>
<p><b>Results.</b> The overall theme was &lsquo;dilemmas&rsquo; in GPs' treatment practice for type 2 diabetes patients. Five main dilemma categories were identified. First, the GPs were hesitant about labelling someone who feels healthy as ill. Second, regarding communicating a diabetes diagnosis and its consequences; should the patient be frightened or comforted? Third, the GPs experienced uncertainty in their role; were they to take responsibility for the care or not? Fourth, the GPs expressed a conflict between lifestyle changes and drug treatment. Fifth, the GPs described difficulties in integrating science into reality.</p>
<p><b>Conclusions.</b> The five dilemmas in the GPs' approach to diabetes patients and the treatment of their cardiovascular risk were related to the GPs' professional role and communication with the patient. To consider these dilemmas in educational efforts is probably essential to achieve improved diabetes care and guideline adherence.</p>
]]></description>
<dc:creator><![CDATA[Fharm, E., Rolandsson, O., Johansson, E. E]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp002</dc:identifier>
<dc:title><![CDATA['Aiming for the stars'--GPs' dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus group interviews]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>114</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>109</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/115?rss=1">
<title><![CDATA['I've broken my neck or something!' The general practice experience of whiplash]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/115?rss=1</link>
<description><![CDATA[
<p><b>Objective.</b> To explore the experiences of patients and GPs concerning the management of mild to moderate whiplash.</p>
<p><b>Methods.</b> Qualitative study using phenomenology. In-depth interviews with patients and their treating GPs. General practices in the northern suburbs of Perth, Western Australia. Participants. Maximum variation sample of nine patients suffering from mild to moderate whiplash and their treating GPs. GPs identified patients with recent whiplash. In-depth interviews were conducted with both groups. Patients were telephoned 3 months later to evaluate progress. Analysis used a constant comparative process and independent transcript review assisted by N-Vivo software.</p>
<p><b>Results.</b> Patients articulated a need to be understood by a physician whom they knew and trusted. For all, the principal underlying concerns were about pain and the financial and physical impact of the injury, particularly in view of its perceived potential to harm the spine. While most patients expected medical interventions to help facilitate speedy recovery, physicians were far more pessimistic. Despite acknowledging the importance of addressing psychological needs, most GPs underestimated the degree of patient distress in the post-injury period. Although guardedly supportive of the local insurance system, GPs were scornful of patients seeking inappropriate compensation.</p>
<p><b>Conclusions.</b> Findings highlight the influence of the patient&ndash;doctor relationship on clinical care in patients with whiplash, suggesting that the path to patient recovery and physician satisfaction may benefit if clinicians better understand patient experiences. The disconnect between patient and practitioner conceptualization of the problem challenges quality patient-centred care.</p>
]]></description>
<dc:creator><![CDATA[Russell, G., Nicol, P.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn106</dc:identifier>
<dc:title><![CDATA['I've broken my neck or something!' The general practice experience of whiplash]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>120</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>115</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/121?rss=1">
<title><![CDATA[Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/121?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> A majority of doctor&ndash;patient meetings result in the patient getting a prescription. This underlines the need for a high-quality prescription process. While studies have been made on single therapeutic drug groups, a complete study of the physicians&rsquo; general thought process that comprises the prescription of all drugs still remains to be made.</p>
<p><b>Objective.</b> To identify variations in ways of understanding drug prescribing among GPs.</p>
<p><b>Methods.</b> A descriptive qualitative study was conducted with 20 Swedish physicians. Informants were recruited purposively and their understandings about prescribing were studied in semi-structured interviews. Data were analysed using a phenomenographic approach.</p>
<p><b>Results.</b> Five categories were identified as follows: (A) GP prescribed safe, reliable and well-documented drugs for obvious complaints; (B) GP sought to convince the patient of the most effective drug treatment; (C) GP chose the best drug treatment taking into consideration the patient's entire life situation; (D) GP used clinical judgement and close follow-up to minimize unnecessary drug prescribing and (E) GP prescribed drugs which are cheap for society and environmentally friendly. The categories are interrelated, but have different foci: the biomedical, the patient and the society. Each GP had more than one view but none included all five. The findings also indicate that complexity increases when a drug is prescribed for primary or secondary prevention.</p>
<p><b>Conclusions.</b> GPs understand prescribing differently despite similar external circumstances. The most significant factor to influence prescribing behaviour was the physician's patient relation approach. GPs may need to reflect on difficulties they face while prescribing to enhance their understandings.</p>
]]></description>
<dc:creator><![CDATA[Rahmner, P. B., Gustafsson, L. L, Larsson, J., Rosenqvist, U., Tomson, G., Holmstrom, I.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn103</dc:identifier>
<dc:title><![CDATA[Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>127</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>121</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/128?rss=1">
<title><![CDATA[Recruitment of practices in primary care research: the long and the short of it]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/128?rss=1</link>
<description><![CDATA[
<p><b>Objective.</b> To determine factors that facilitated or hindered recruitment of general practices into a large New Zealand primary care project that aimed to determine general practice characteristics of immunization coverage.</p>
<p><b>Methods.</b> The project had a multi-level recruitment strategy requiring recruitment of randomly selected practices before randomly selecting GPs, practice nurses and caregivers of children enrolled at those practices. Detailed quantitative and qualitative recruitment data were recorded on an access database. Post-recruitment, recruiters underwent semi-structured interviews. Analysis was mixed method, with triangulation of descriptive statistics of the number of calls and time course to recruitment and general inductive thematic analysis of qualitative data.</p>
<p><b>Results.</b> Identifying key decision makers and how individual practice processes work can save significant recruitment time. Factors identified as assisting practice recruitment included using a personal approach from doctor to doctor, getting buy-in from all practice staff, streamlining the research process to minimize disruption to the practice and flexibility to accommodate practices.</p>
<p><b>Conclusions.</b> The task of recruiting should not be underestimated. Adequate time and resource need to be allocated from the onset. Long periods where practices have no added burdens such as audits, mass vaccination programmes or influenza season are unlikely, therefore there are always considerable challenges in recruiting practices for research. Remaining flexible to individual practice styles and influences and acknowledging the commitment of participants is important.</p>
]]></description>
<dc:creator><![CDATA[Goodyear-Smith, F., York, D., Petousis-Harris, H., Turner, N., Copp, J., Kerse, N., Grant, C.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp015</dc:identifier>
<dc:title><![CDATA[Recruitment of practices in primary care research: the long and the short of it]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>136</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>128</prism:startingPage>
<prism:section>Health Services Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/137?rss=1">
<title><![CDATA[Economic evaluation of early administration of prednisolone and/or aciclovir for the treatment of Bell's palsy]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/137?rss=1</link>
<description><![CDATA[
<p><b>Objectives.</b> Bell's palsy (BP), which causes facial paralysis, affects 11&ndash;40 people per 100 000 per annum in the UK. Its cause is unknown but as many as 30% of patients have continuing facial disfigurement, psychological difficulties and occasionally facial pain. We present an randomised controlled trial (RCT)-based economic evaluation of the early administration of steroids (prednisolone) and/or antivirals (acyclovir) compared to placebo, for treatment of BP.</p>
<p><b>Methods.</b> The RCT was not powered to detect differences in the cost-effectiveness; therefore, we adopted a decision analytic model approach as a way of gaining precision in our cost-effectiveness comparisons [e.g. prednisolone only (PO) versus acyclovir only versus prednisolone and acyclovir versus placebo, prednisolone versus no prednisolone (NP) and acyclovir versus no acyclovir]. We assumed that trial interventions affect the probability of being cured/not cured but their consequences are independent of the initial therapy. We used the percentage of individuals with a complete recovery (based on House&ndash;Brackmann grade = 1) at 9 months and Quality Adjusted Life Years (e.g. derived on responses to the Health Utilities Index III) as measures of effectiveness. Other parameter estimates were obtained from trial data.</p>
<p><b>Results.</b> PO dominated&mdash;i.e. was less costly and more effective&mdash;all other therapy strategies in the four arms model [77% probability of cost-effective (CE)]. Moreover, Prednisolone dominated NP (77% probability of being CE at &pound;30 000 threshold) while no acyclovir dominated aciclovir (85% chance of CE), in the two arms models, respectively.</p>
<p><b>Conclusions.</b> Treatment of BP with prednisolone is likely to be considered CE while treatment with acyclovir is highly unlikely to be considered CE. Further data on costs and utilities would be useful to confirm findings.</p>
]]></description>
<dc:creator><![CDATA[Hernandez, R., Sullivan, F, Donnan, P, Swan, I, Vale, L, for the BELLS Trial Group]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn107</dc:identifier>
<dc:title><![CDATA[Economic evaluation of early administration of prednisolone and/or aciclovir for the treatment of Bell's palsy]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>144</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>137</prism:startingPage>
<prism:section>Health Services Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/145?rss=1">
<title><![CDATA[Evaluation of the management of heart failure in primary care]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/145?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> The extent to which guidelines for the treatment of heart failure are currently followed in primary care in the UK is unclear.</p>
<p><b>Objective.</b> To evaluate the prevalence of heart failure and the pharmacological management of heart failure in relation to European Society of Cardiology (ESC) and National Institute for Health and Clinical Excellence guidelines.</p>
<p><b>Methods.</b> Retrospective cohort study using routinely collected data from 163 general practices across Great Britain contributing data to the Doctors Independent Network (DIN-LINK) database over a 5-year period until December 31, 2006.</p>
<p><b>Results.</b> From a patient population of nearly 1.43 million, 9311 patients with heart failure were identified [mean age 78 years (SD 12)], giving an estimated prevalence of 0.7%. Of these, 7410 (79.6%) were prescribed a loop diuretic, 6620 (71.1%) were prescribed an angiotensin-converting enzyme (ACE) inhibitor or ARB, 3403 (36.6%) were prescribed &beta;-blockers but only 2732 (29.3%) were prescribed an ACE inhibitor or ARB and a &beta;-blocker in combination. Thirty-five per cent of patients prescribed ACE inhibitor and 11.5% of those prescribed &beta;-blockers met ESC guideline target doses. Age, gender and comorbidity predicted whether patients received &beta;-blocker or ACE inhibitor with younger males being more likely to receive maximal therapy.</p>
<p><b>Conclusions.</b> These data suggest that while most patients with heart failure receive an ACE inhibitor/ARB in primary care, few are titrated to target dose and many do not receive a &beta;-blocker. Optimum treatment appears to be most likely for young men. New strategies are required to ensure equitable and optimal treatment for all.</p>
]]></description>
<dc:creator><![CDATA[Calvert, M. J, Shankar, A., McManus, R. J, Ryan, R., Freemantle, N.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn105</dc:identifier>
<dc:title><![CDATA[Evaluation of the management of heart failure in primary care]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>153</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>145</prism:startingPage>
<prism:section>Health Services Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/154?rss=1">
<title><![CDATA[The effectiveness of exercise in the management of post-natal depression: systematic review and meta-analysis]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/154?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Post-natal depression (PND) is a serious mental health problem that may be reduced by exercise. National Institute for Health and Clinical Excellence in England have recommended that health professions should consider exercise as a treatment for PND.</p>
<p><b>Objective.</b> To evaluate the effectiveness of exercise in the management of PND.</p>
<p><b>Methods.</b> Systematic review and meta-analysis of randomized controlled trials (RCTs). Data sources involved in the study are Cochrane Library (CENTRAL), MEDLINE, EMBASE, PsycINFO, Science Citation Index and Social Science Citation Index, CINAHL and SPORTDiscus.</p>
<p><b>Review methods.</b> Selection criteria are RCTs and quasi-RCTs that compared any type of exercise intervention with other treatments or no treatment in women with PND. Database searches and abstracts were reviewed independently by two authors. The Delphi criteria were used to assess the quality of included studies. Data were abstracted by two reviewers. Data synthesis is meta-analysis. Main outcome measure is post-natal depression.</p>
<p><b>Results.</b> Five studies fulfilled our inclusion criteria. When compared with no exercise, exercise reduced symptoms of PND {SMD = &ndash;0.81 [95% confidence interval (CI): &ndash;1.53 to &ndash;0.10]}. The overall WMD in Edinburgh Post-natal Depression Scale score was &ndash;4.00 points (95% CI: &ndash;7.64 to &ndash;0.35). However, significant heterogeneity was found. The effect size was reduced considerably (non-significant) when the trial that included exercise as a co-intervention with social support was excluded [SMD = &ndash;0.42 (95% CI: &ndash;0.90 to 0.05)] and heterogeneity was no longer present.</p>
<p><b>Conclusions.</b> Due to heterogeneity, it is uncertain whether exercise reduces symptoms of PND. Caution is also required when interpreting findings from the main analysis as only five small trials were included and CIs were wide. Further research is evidently required.</p>
]]></description>
<dc:creator><![CDATA[Daley, A., Jolly, K., MacArthur, C.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn101</dc:identifier>
<dc:title><![CDATA[The effectiveness of exercise in the management of post-natal depression: systematic review and meta-analysis]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>162</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>154</prism:startingPage>
<prism:section>Health Services Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/2/163?rss=1">
<title><![CDATA[Does a system of instalment dispensing for newly prescribed medicines save NHS costs? Results from a feasibility study]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/2/163?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> In view of the increasing cost of general practice of drug prescribing, it is important to look at ways of reducing drug wastage and thereby improve the cost-effectiveness of prescribing.</p>
<p><b>Objective.</b> To determine the costs and cost savings to the NHS of instalment dispensing for newly prescribed medicines and to quantify the extra costs incurred by patients.</p>
<p><b>Methods.</b> Patients were randomized to receive either a normal (<I>n</I> = 103) or an instalment (<I>n</I> = 101) prescription.</p>
<p><b>Results.</b> The difference between prescribed and dispensed drug costs in the intervention group was &pound;0.98 per patient (95% confidence interval &pound;0.14&ndash;&pound;1.82), giving a 7% reduction in drug costs. The costs of the additional pharmacy time required to implement the intervention was calculated to be &pound;5.02 per patient.</p>
<p><b>Conclusions.</b> Introduction of a system of instalment dispensing produced savings in the general practice of drugs bill, but these were not large enough to offset additional costs for pharmacists.</p>
]]></description>
<dc:creator><![CDATA[Millar, J., McNamee, P., Heaney, D., Selvaraj, S., Bond, C., Lindsay, S., Morton, M.]]></dc:creator>
<dc:date>2009-03-13</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn100</dc:identifier>
<dc:title><![CDATA[Does a system of instalment dispensing for newly prescribed medicines save NHS costs? Results from a feasibility study]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>168</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>163</prism:startingPage>
<prism:section>Health Services Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/1?rss=1">
<title><![CDATA[Prevalence of COPD in primary care: no room for complacency]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[White, P.]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmp001</dc:identifier>
<dc:title><![CDATA[Prevalence of COPD in primary care: no room for complacency]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>2</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>1</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/3?rss=1">
<title><![CDATA[Is COPD a rare disease? Prevalence and identification rates in smokers aged 40 years and over within general practice in Germany]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/3?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> According to literature, COPD rates are high in spite of decreasing rates of main risk factors smoking and air pollution in developed countries. general practice is a good place to survey unbiased prevalence rates. Ten studies done in general practice over the last 20 years found prevalence rates among smokers between 13.1% and 92.1%.</p>
<p><b>Objective.</b> Prevalence and detection rates of COPD in smokers in German general practice.</p>
<p><b>Methods.</b> Twenty-eight of 34 invited and eligible GP surgeries in/around Duesseldorf, Germany, took part in the non-announced 2-day investigation of all smokers (&ge;40 years) who visited the surgeries. Lung function test by hand-held spirometer, peak flow, sympton part of St George's Respiratory Questionnaire, and data on smoking habits were used. GOLD criteria for COPD were employed. GPs had to give their diagnosis not knowing the test results.</p>
<p><b>Results.</b> Of 3157 patients attending the 28 surgeries, 538 were smokers. Four hundred and thirty-seven of these agreed to participate, 5 had to be excluded for medical reasons/unacceptable spirometry. Three hundred and ninety-eight patients have not been previously diagnosed with COPD or asthma. Thirty patients were disgnosed with COPD, making a prevalence of 6.9%, of which 15 patients were already known as having COPD.</p>
<p><b>Conclusion.</b> Our result of low prevalence differs strongly from all other studies in general practice. Considering our study design which avoids selection bias found in nearly all other studies (no pre-announcement, no self-selection of patients or GPs, high participation rate and testing all patients), we strongly believe that our findings reflect the current situation of COPD in German general practice.</p>
]]></description>
<dc:creator><![CDATA[Gingter, C., Wilm, S., Abholz, H.-H.]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn084</dc:identifier>
<dc:title><![CDATA[Is COPD a rare disease? Prevalence and identification rates in smokers aged 40 years and over within general practice in Germany]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>9</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>3</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/10?rss=1">
<title><![CDATA[C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/10?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> There is uncertainty regarding the diagnostic value of C-reactive protein (CRP) in patients presenting with symptoms suggestive of community-acquired pneumonia (CAP) in community or ambulatory settings.</p>
<p><b>Objective.</b> We assessed the diagnostic value of CRP in primary care and accident and emergency departments in terms of ruling in or ruling out CAP.</p>
<p><b>Methods.</b> Diagnostic accuracy systematic review, we searched PubMed from January 1966 to September 2008 and EMBASE from January 1980 to September 2008 using a diagnostic accuracy search filter. We included cross-sectional or cohort studies that assess the diagnostic utility of CRP at different cut-points against a reference standard of chest X-ray. We calculated pooled positive and negative likelihood ratios (LRs) and assessed heterogeneity using the <I>I</I><sup>2</sup> index.</p>
<p><b>Results.</b> Eight studies incorporating 2194 patients were included. The median prevalence of CAP was 14.6% (range 5%&ndash;89%). At a CRP cut-point of &le;20 mg/l, the pooled positive LR+ was 2.1 [95% confidence interval (CI) 1.8&ndash;2.4] and the pooled negative LR&ndash; was 0.33 (95% CI 0.25&ndash;0.43). At the two other CRP cut-points (&le;50, &gt;100 mg/l), the results were heterogeneous, so the pooled results should be interpreted with caution.</p>
<p><b>Conclusions.</b> CRP may be of value in ruling out a diagnosis of CAP in situations where the probability of CAP &gt;10%, typically accident and emergency departments. In primary care, additional diagnostic testing with CRP is unlikely to alter the probability of CAP sufficiently to change subsequent management decisions such as antibiotic prescribing or referral to hospital.</p>
]]></description>
<dc:creator><![CDATA[Falk, G., Fahey, T.]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn095</dc:identifier>
<dc:title><![CDATA[C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>21</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>10</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/22?rss=1">
<title><![CDATA[Can we measure the ankle-brachial index using only a stethoscope? A pilot study]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/22?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Ankle-brachial index (ABI) is an excellent method for the diagnosis of peripheral arterial disease (PAD) when it is performed with Doppler. However, this device is not always available for primary care physicians. The ABI measured with stethoscope is an easy alternative approach, but have not been proved to be useful.</p>
<p><b>Objective.</b> To assess the accuracy of the ABI measured using a stethoscope comparatively to that of the current eligible method for the diagnosis of PAD, the Doppler ABI, and describe the characteristics of this new approach.</p>
<p><b>Methods.</b> We conducted a diagnostic study of ABI measured with a stethoscope and a Doppler probe and compared the results. Eighty-eight patients were accessed by both methods.</p>
<p><b>Results.</b> Mean stethoscope ABI, 1.01 &plusmn; 0.15, and mean Doppler ABI, 1.03 &plusmn; 0.20, (<I>P</I> = 0.047) displayed a good correlation. Measurements of stethoscope ABI diagnostic accuracy in recognizing a Doppler ABI are described. The comparison of this data with the current gold standard method results gave a sensitivity of 71.4% [95% confidence interval (CI), 41.9&ndash;91.6] and specificity of 91.0% (95% CI, 81.5&ndash;96.6), with predictive positive value of 62.5% (95% CI, 38.6&ndash;81.5) and negative predictive value of 93.8% (95% CI, 85.2&ndash;97.6). The study accuracy was 87.7%. The area under the ROC curve was 0.895 (95% CI, 0.804&ndash;0.986, <I>P</I> &lt; 0.0001).</p>
<p><b>Conclusions.</b> According to our study, the stethoscope ABI is a useful method to detect PAD and it may be suitable for its screening in the primary care setting.</p>
]]></description>
<dc:creator><![CDATA[Carmo, G., Mandil, A, Nascimento, B., Arantes, B., Bittencourt, J., Falqueto, E., Ribeiro, A.]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn086</dc:identifier>
<dc:title><![CDATA[Can we measure the ankle-brachial index using only a stethoscope? A pilot study]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>26</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>22</prism:startingPage>
<prism:section>Primary Care Epidemiology</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/27?rss=1">
<title><![CDATA[Features of the management of depression in gay men and men with HIV from the perspective of Australian GPs]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/27?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> In contrast to the broad literature on depression in the general population, little is known about the management of depression affecting gay men and HIV-positive men attending general practice clinics.</p>
<p><b>Objective.</b> This paper explores qualitative descriptions of how depression in gay men and HIV-positive men is managed by GPs.</p>
<p><b>Methods.</b> As part of the qualitative component of a mixed method study on HIV and depression, semi-structured interviews were conducted with 16 GPs in three geographical settings in Australia: Sydney, Adelaide and a rural coastal town.</p>
<p><b>Results.</b> GPs identified a range of features in their experience of managing depression in gay men and in HIV-positive men. Some were common to the care of other groups with depression, but this paper reports on features unique to this patient group. These include capitalizing on the high frequency of contact with this patient group, taking advantage of the specialist multidisciplinary teams who provide support, building upon the unusual willingness of this patient group to take medication, appreciating the central importance to many gay men of sexual functioning, and recreational drug use, responding to social isolation in this patient group and coping with increasing challenges for the HIV general practice workforce.</p>
<p><b>Conclusions.</b> Despite the identification of several key strengths in working with this patient group, the ability of GPs to develop their capacity to manage depression in gay men and men with HIV is uncertain in the context of a growing range of challenges for GPs in both mental health and HIV care.</p>
]]></description>
<dc:creator><![CDATA[Newman, C. E, Kippax, S. C, Mao, L., Rogers, G. D, Saltman, D. C, Kidd, M. R]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn089</dc:identifier>
<dc:title><![CDATA[Features of the management of depression in gay men and men with HIV from the perspective of Australian GPs]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>33</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>27</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/34?rss=1">
<title><![CDATA[GPs' explanatory models for irritable bowel syndrome: a mismatch with patient models?]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/34?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Inconsistencies in doctors&rsquo; views about causes and treatment of irritable bowel syndrome (IBS) lead to frustration for doctors and in doctor&ndash;patient interactions. Diagnosis by GPs does not correspond well to established diagnostic criteria.</p>
<p><b>Objective.</b> To understand GPs&rsquo; explanatory models (EMs) and management strategies for IBS.</p>
<p><b>Methods.</b> Qualitative, semi-structured interviews with 30 GPs (15 from the UK and 15 from The Netherlands).</p>
<p><b>Results.</b> Diagnosing IBS in primary care is a complex process, involving symptoms, tests, history and risk calculation. GPs were uncertain about the aetiology of IBS, but often viewed it as a consequence of disordered bowel activity in response to stress, which was viewed as a function of people's responses to their environment. GPs tend to diagnose IBS by exclusion, rather than with formal diagnostic criteria. They endeavoured to present the IBS diagnosis to their patients in a way that they would accept, fearing that many would not be satisfied with a diagnosis that had no apparent physical cause. GPs focused on managing symptoms and reassuring patients. Many GPs felt that patients needed to take the responsibility for managing their IBS and for minimizing its impact on their daily lives. However, the GPs had limited awareness of the extent to which IBS affected their patients&rsquo; daily lives.</p>
<p><b>Conclusions.</b> GPs&rsquo; diagnostic procedures and EMs for IBS are at odds with patient expectations and current guidelines. Shared discussion of what patients believe to be triggers for symptoms, ways of coping with symptoms and the role of medication may be helpful.</p>
]]></description>
<dc:creator><![CDATA[Casiday, R. E, Hungin, A., Cornford, C. S, de Wit, N. J, Blell, M. T]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn088</dc:identifier>
<dc:title><![CDATA[GPs' explanatory models for irritable bowel syndrome: a mismatch with patient models?]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>39</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>34</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/40?rss=1">
<title><![CDATA[Patients' explanatory models for irritable bowel syndrome: symptoms and treatment more important than explaining aetiology]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/40?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Irritable bowel syndrome (IBS) is a common condition associated with no certain organic cause, though diet and stress are widely implicated. The condition is frustrating for both sufferers and doctors, and there are problems in diagnosing and treating the condition. Eliciting explanatory models (EMs) is a useful tool for understanding how individuals relate to their illnesses and their expectations for treatment, particularly for illnesses with uncertain aetiology like IBS.</p>
<p><b>Objectives.</b> To understand the EMs, experiences and expectations for management of patients with IBS.</p>
<p><b>Methods.</b> Qualitative, semi-structured interviews were conducted with 51 primary care patients (31 in the UK, 20 in The Netherlands) meeting the Rome II diagnostic criteria for IBS.</p>
<p><b>Results.</b> Although IBS often had a significant dampening effect on daily life, IBS patients made great efforts not to allow the condition to take over their lives. Triggers of symptoms were more important to patients than understanding the underlying aetiology of IBS. Diet and stress were both recognized as important triggers, but views about which foods were problematic and the extent to which stress was modifiable were inconsistent. Diagnosis and treatment were often a confusing and frustrating process, and patients often expected more diagnostic tests than they were offered before receiving a diagnosis of IBS. However, the often poor outcome of medical interventions does not, in general, appear to have a negative impact on the patient&ndash;doctor relationship.</p>
<p><b>Conclusions.</b> Clinicians should be aware of the extensive impact of IBS on sufferers&rsquo; daily life and the frustration that results from repeatedly trying treatments with little effect. Clearly explaining the guidelines for diagnosing IBS and the range of treatment options may help patients to make sense of the diagnostic and treatment processes. The personal EM should be addressed during the consultation with the IBS patient, ensuring that any successive medical interventions match with the patients&rsquo; disease perception.</p>
]]></description>
<dc:creator><![CDATA[Casiday, R. E, Hungin, A P S, Cornford, C. S, de Wit, N. J, Blell, M. T]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn087</dc:identifier>
<dc:title><![CDATA[Patients' explanatory models for irritable bowel syndrome: symptoms and treatment more important than explaining aetiology]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>47</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>40</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/48?rss=1">
<title><![CDATA[UK research staff perspectives on improving recruitment and retention to primary care research; nominal group exercise]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/48?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Primary care studies often encounter recruitment difficulties, but there is little evidence to inform solutions. As part of a National Institute for Health Research School for Primary Care Research and UK Clinical Research Network programme, we elicited research staff perspectives on factors facilitating or obstructing recruitment.</p>
<p><b>Objective.</b> To identify factors that experienced research staff consider important in successful recruitment and retention and their confidence in achieving them.</p>
<p><b>Methods.</b> An iterative series of three workshops was held. The third used a modified nominal group technique to categorize whether factors related to the &lsquo;context&rsquo; in which the research took place, the &lsquo;content&rsquo; of the study or the recruitment &lsquo;process&rsquo; and to prioritize them by their importance to success.</p>
<p><b>Results.</b> Eighteen research staff participated in the prioritization workshop. They prioritized positive attitudes of primary care staff towards research and trust of researchers by potential participants as major contextual factors affecting recruitment. Studies needed to be considered safe and relevant by staff and fit with practice systems. They proposed that researchers strengthen relationships with staff and participants and minimize workload for primary care teams. Although confident in many recruitment processes, respondents remained uncertain how to achieve cultural change so that research became part of normal practice activity and how best to motivate patients to participate.</p>
<p><b>Conclusions.</b> Research workers taking part identified factors which might be important in recruitment, several of which they expressed little confidence in addressing. Understanding how to improve recruitment is crucial if current efforts to strengthen primary care research are to bear fruit.</p>
]]></description>
<dc:creator><![CDATA[Graffy, J., Grant, J., Boase, S., Ward, E., Wallace, P., Miller, J., Kinmonth, A. L.]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn085</dc:identifier>
<dc:title><![CDATA[UK research staff perspectives on improving recruitment and retention to primary care research; nominal group exercise]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>55</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>48</prism:startingPage>
<prism:section>Qualitative Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/56?rss=1">
<title><![CDATA[A feasible model for prevention of functional decline in older home-dwelling people--the GP role. A municipality-randomized intervention trial]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/56?rss=1</link>
<description><![CDATA[
<p><b>Background.</b> Danish municipalities are required by state law to offer two annual home visits to all non-disabled citizens &ge;75 years. Visits are primarily carried out by district nurses. GPs are rarely directly involved.</p>
<p><b>Objective.</b> To evaluate the effects of offering an educational programme to home visitors and GPs on mortality, functional ability and nursing home admissions among home-dwelling older people.</p>
<p><b>Methods.</b> Design: Municipality pair-matched randomized trial.</p>
<p>Setting: Danish primary care.</p>
<p>Subject: 2863 home-dwelling 75-year-olds and 1171 home-dwelling 80-year-olds living in 34 municipalities.</p>
<p>Intervention: Home visitors received regular education for a period of 3 years. In nine of 17 intervention municipalities, GPs participated in one small group training session during the first year.</p>
<p>Main outcome measures: Mortality, functional ability and nursing home admission during 41/2 years of follow-up.</p>
<p><b>Results.</b> Intervention was not associated with mortality. Home visitor education was associated with reduction in functional decline among home-dwelling 80-year-olds after the three intervention years in municipalities where GPs accepted and participated in small group-based training. Effects did not persist after the intervention ended. When analyses were restricted to baseline non-disabled persons, intervention was associated with beneficial effects on functional ability after three intervention years among 80-year-olds, regardless of education was given to home visitors alone or to visitors and GPs. Nursing home admission rates were lower among the 80-year-olds living in the intervention municipalities.</p>
<p><b>Conclusion.</b> A brief, practicable interdisciplinary educational programme for primary care professionals postponed functional decline in non-disabled 80-year-old home-dwelling persons.</p>
]]></description>
<dc:creator><![CDATA[Vass, M, Avlund, K, Siersma, V, Hendriksen, C]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn094</dc:identifier>
<dc:title><![CDATA[A feasible model for prevention of functional decline in older home-dwelling people--the GP role. A municipality-randomized intervention trial]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>64</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>56</prism:startingPage>
<prism:section>Health Services Research</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/65?rss=1">
<title><![CDATA[How to obtain excellent response rates when surveying physicians]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/65?rss=1</link>
<description><![CDATA[
<p>This paper outlines ways to maximize response rates to surveys by summarizing the most relevant literature to date and demonstrating how these techniques have resulted in consistently high rates of return in family practice research. We describe the methodology used in recent surveys of physicians conducted by the Centre for Studies in Family Medicine through its Thames Valley Family Practice Research Unit, located in London, Ontario, Canada and funded by the Ontario Ministry of Health and Long-Term Care. The identification and implementation of these techniques to maximize response rates is critical, as primary health care researchers often rely on information gathered through questionnaires to study physicians' practice profiles, experiences and attitudes. Four separate and distinct mailed surveys of physicians using a modified Dillman approach were conducted from 2001 to 2004. The sampling strategies, topics, types of questions and response formats of these surveys varied. The first survey did not use any incentives or recorded delivery/registered mail and received a response rate of 48%. In sharp contrast, the other three surveys obtained responses rates of 76%, 74%, 74%, respectively, achieved through the use of gift certificates and recorded delivery/registered mail. Sending a survey by recorded delivery/registered mail tends to result in the survey package being given priority in the physicians' incoming mail at the practice. Gift certificates partially compensate physicians for time spent completing the survey and recognition of the time required is appreciated. The response rates achieved provide strong evidence to support the use of monetary incentives and recorded delivery/registered mail (along with the Dillman approach) in survey research. It is anticipated that this evidence will be used by other researchers to justify requests for funding to cover the costs associated with incentives and recorded delivery/registered mail. We recommend the use of these strategies to maximize response rates and improve the quality of this type of primary health care research.</p>
]]></description>
<dc:creator><![CDATA[Thorpe, C, Ryan, B, McLean, S., Burt, A, Stewart, M, Brown, J., Reid, G., Harris, S]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn097</dc:identifier>
<dc:title><![CDATA[How to obtain excellent response rates when surveying physicians]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>68</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>65</prism:startingPage>
<prism:section>Methodological Review Articles</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/69?rss=1">
<title><![CDATA[Clinically relevant diagnostic research in primary care: the example of B-type natriuretic peptides in the detection of heart failure]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/69?rss=1</link>
<description><![CDATA[
<p>With the emergence of novel diagnostic tests, e.g. point-of-care tests, clinically relevant empirical evidence is needed to assess whether such a test should be used in daily practice. With the example of the value of B-type natriuretic peptides (BNP) in the diagnostic assessment of suspected heart failure, we will discuss the major methodological issues crucial in diagnostic research; most notably the choice of the study population and the data analysis with a multivariable approach. BNP have been studied extensively in the emergency care setting, and also several studies in the primary care are available. The usefulness of this test when applied in combination with other readily available tests is still not adequately addressed in the relevant patient domain, i.e. those who are clinically suspected of heart failure by their GP. Future diagnostic research in primary care should be targeted much more at answering the clinically relevant question &lsquo;Is it useful to add this (new) test to the other tests I usually perform, including history taking and physical examination, in patients I suspect of having a certain disease&rsquo;.</p>
]]></description>
<dc:creator><![CDATA[Kelder, J. C, Rutten, F. H, Hoes, A. W]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn096</dc:identifier>
<dc:title><![CDATA[Clinically relevant diagnostic research in primary care: the example of B-type natriuretic peptides in the detection of heart failure]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>74</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>69</prism:startingPage>
<prism:section>Methodological Review Articles</prism:section>
</item>

<item rdf:about="http://fampra.oxfordjournals.org/cgi/content/short/26/1/75?rss=1">
<title><![CDATA[The work and research of a single non-academic family physician]]></title>
<link>http://fampra.oxfordjournals.org/cgi/content/short/26/1/75?rss=1</link>
<description><![CDATA[
<p>This review of my own work over 30 years aims to help others decide whether they should and could pursue an interest in research in primary care. Lessons from failure are considered as well as how to be opportunistic in research. I suggest audit is a good place to start research as it requires several of the same disciplines. The difficult issue of working successfully with others is addressed along with a publication strategy. I illustrate some of the advantages and disadvantages of undertaking research from general practice. Finally, I discuss how personal research can lead to a higher degree.</p>
]]></description>
<dc:creator><![CDATA[Holden, J.]]></dc:creator>
<dc:date>2009-01-28</dc:date>
<dc:identifier>info:doi/10.1093/fampra/cmn090</dc:identifier>
<dc:title><![CDATA[The work and research of a single non-academic family physician]]></dc:title>
<dc:publisher>World Organization of Family Doctors</dc:publisher>
<prism:number>1</prism:number>
<prism:volume>26</prism:volume>
<prism:endingPage>78</prism:endingPage>
<prism:publicationDate>2009-02-01</prism:publicationDate>
<prism:startingPage>75</prism:startingPage>
<prism:section>Special Discussion paper</prism:section>
</item>

</rdf:RDF>